ID: ALA3245766

Max Phase: Preclinical

Molecular Formula: C17H23ClN2O3

Molecular Weight: 302.37

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cl.NC(=O)CCCNCC(O)COc1cccc2ccccc12

Standard InChI:  InChI=1S/C17H22N2O3.ClH/c18-17(21)9-4-10-19-11-14(20)12-22-16-8-3-6-13-5-1-2-7-15(13)16;/h1-3,5-8,14,19-20H,4,9-12H2,(H2,18,21);1H

Standard InChI Key:  SHTSPMRWWZUMBP-UHFFFAOYSA-N

Associated Targets(non-human)

Heart 171 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 302.37Molecular Weight (Monoisotopic): 302.1630AlogP: 1.43#Rotatable Bonds: 9
Polar Surface Area: 84.58Molecular Species: BASEHBA: 4HBD: 3
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.58CX LogP: 1.01CX LogD: -1.14
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.61Np Likeness Score: -0.57

References

1. Rauls DO, Baker JK..  (1979)  Relationship of nonspecific antiarrhythmic and negative inotropic activity with physicochemical parameters of propranolol analogues.,  22  (1): [PMID:423187] [10.1021/jm00187a018]

Source